Gentium Aktie

Gentium für 0 Euro bei ZERO ordern (zzgl. Spreads)

WKN: A0ERUA / ISIN: US37250B1044

<
Kurse + Charts + Realtime
Kurs + Chart
Times + Sales
Börsenplätze
Historisch
>
<
News + Analysen
News + Adhoc
Analysen
Kursziele
>
<
Unternehmen
Termine
Profil
>
<
zugeh. Wertpapiere
Zertifikate
Optionsscheine
Knock-Outs
>
20.12.2013 20:58:00

Jazz Pharmaceuticals plc -- Moody's: Jazz pays high price for Gentium's modest EBITDA

New York, December 20, 2013 -- Moody's Investors Service commented that Jazz Pharmaceutical's announced acquisition of Gentium Sp.A. is credit negative because of the high purchase price relative to near-term EBITDA contribution. Jazz will pay $57 per share for Gentium, or roughly $1 billion, for an EBITDA contribution of $20 to $30 million in 2014. Jazz is rated Ba3 with a stable rating outlook and Gentium is unrated.

Vollständigen Artikel bei Moodys lesen